SIRION and Sanofi partner on next-gen AAV gene therapy vectors
SIRION and Sanofi are partnering to develop improved AAV vectors to overcome some of the challenges facing gene therapies. The…
By
SIRION and Sanofi are partnering to develop improved AAV vectors to overcome some of the challenges facing gene therapies. The…
ByGerman-headquartered pharma company Bayer has published its 2020 annual report. The report suggests that Bayer had a robust 2020 despite…
ByAbbVie and Caribou are partnering to develop next-generation off-the-shelf CAR-T therapies for oncology indications. The collaboration centres around Caribou’s chRDNA…
ByNew and existing investors have supported TCR therapy-focused TScan with $100m in an oversubscribed Series C round. The money will…
ByLike the rest of the pharma industry, cell and gene therapy companies have been disrupted by the pandemic. However, the…
ByNovartis’s Zolgensma, a gene therapy for young children with SMA, leverages REGENXBIO’s NAV AAV9 vector to deliver the SMN gene…
ByWhile moving cryogenically and deep-frozen-state stored biomaterials it is critical to not only provide the right equipment, but also ensure…
Be Bio has closed a $52m Series A round led by Atlas Ventures and RA Capital. Co-founded by Longwood Fund…
By